Metformin was also included as a control since it is the most widely used drug for the treatment of diabetes, which among its multiple mechanisms of action activates AMPK, generating a signaling cascade that ends in the sensitization to insulin in the receptor, allowing this hormone to carry out its function correctly, thus reducing glucose levels in peripheral blood [52]. This evidence concerns the gene INS and diabetes mellitus.